Clinical Trial Update: NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating NEPA to prevent chemotherapy-induced nausea and vomiting in breast cancer patients (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• NEPA (netupitant/palonosetron)

Snippet

Sponsor: Consorzio Oncotech | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED